LE GRAND, Bruno B,JUNQUERO, Didier D,MONJOTIN, Nicolas N,.勒格蘭德,.洪克羅,.蒙若廷
申请号：
HK16110155.2
公开号：
HK1221913A
申请日:
2016.08.25
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
